Pharmacological Characterization of Cholinergic Receptors in a Human Neuroblastoma Cell Line

Authors:

Abstract
A human neuroblastoma cell line, IMR32, has been characterized as far as morphology, membrane receptors for neurotransmitters, and uptake and release of [3H]3,4‐dihydroxyphenylethylamine ([3H]dopamine). These cells expressed at their surface both nicotinic and muscarinic cholinergic receptors, revealed by [125I]α‐bungarotoxin and [3H]quinuclidinylbenzilate ([3H]QNB) binding, respectively. [125I]α‐Bungarotoxin binding was efficiently inhibited by α‐bungarotoxin, nicotine, carbachol, andd‐tubocurarine. [3H]QNB binding was competitively inhibited by atropine, pirenzepine, and carbachol. Hexamethonium did not affect the binding of either ligand. In competition experiments with [3H]QNB, pirenzepine recognized only one binding site with “low affinity,” and carbachol recognized two sites with different affinities, β‐adrenergic receptors were present in a very low amount, whereas α‐adrenergic and dopaminergic receptors were not detectable. IMR32 cells had an imipramine‐sensitive [3H]dopamine uptake, but carbachol, high levels of K+, the calcium ionophore A23187, and α‐latrotoxin were not able to induce release of [3H]dopamine that had been taken up. The ultrastructural analysis showed that IMR32 cells contained very few dense‐core vesicles, suggesting a low storage capacity for neurotransmitter. These cells could be an useful in vitro model for studying neurotransmitter receptors of the human CNS.

This publication has 28 references indexed in Scilit: